
Addus HomeCare (ADUS) Stock Forecast & Price Target
Addus HomeCare (ADUS) Analyst Ratings
Bulls say
Addus HomeCare Corp is showing robust organic revenue growth, with the personal care segment achieving a notable 12.3% year-over-year increase in 2023, and maintaining a positive trajectory with projected growth rates of 7.7% in 2024 and 7.4% year-to-date in 2025. The recent 2.6% Medicare Hospice rate increase effective October 2025 is expected to bolster growth in the hospice segment, which is transitioning to a stable growth phase characterized by low-single-digit rate updates and additional revenue from operational improvements and mergers and acquisitions. The combination of a supportive reimbursement environment, strong fundamentals in the personal care segment, and strategic growth opportunities positions Addus HomeCare favorably for continued financial performance.
Bears say
Addus HomeCare has experienced same-store declines in 2025 year-to-date due to challenges posed by Medicaid redeterminations, resulting in administrative bottlenecks that hinder the onboarding of new patients and lead to higher discharge rates. Approximately 97% of the company's segment revenues are at risk due to ongoing uncertainties surrounding the future Medicaid funding environment, particularly related to the One Big Beautiful Bill Act (OBBBA). While the company maintains a seemingly favorable long-term demand backdrop, the disconnect between its equity performance and broader market dynamics raises concerns about its stability and future growth potential.
This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.
Addus HomeCare (ADUS) Analyst Forecast & Price Prediction
Start investing in Addus HomeCare (ADUS)
Order type
Buy in
Order amount
Est. shares
0 shares